KMID : 0043319990220020151
|
|
Archives of Pharmacal Research 1999 Volume.22 No. 2 p.151 ~ p.156
|
|
Cytotoxicity of Two Novel Cisplatin Analogues, (CPA)2Pt[DOLYM] and (DACH)Pt[DOLYM], to Human Cancer Cells In Vitro
|
|
Choi Sang-Un
Kim Kwang-Hee Choi Eun-Jung Park Sung-Hee Kim Kwan-Mook Sohn Youn-Soo Lee Chong-Ock
|
|
Abstract
|
|
|
Despite the impressive antitumor activity of cisplatin, two major limitations of the drug, that is severe side effects and drug-resistance of cancer cells, make its use difficult of r cancer therapy. These limitations have resulted in a greate deal of effort having been expended into structural modifications of cisplatin. In this study, we tested two novel cisplatin analogues, (CPA)2 Pt[DOLYM] (COMP-I) and (DACH)Pt[DOLYM] (CoMP-II), for the mode of cytotoxic action against human tumor cells comparing with cisplatin and carboplatin in vitro. These two novel analogues had considerable cytotoxic activities against five kinds of human solid tumor cells, and especially COMP-II was more effective on HCT15 colon cancer cells than other compounds. In addition, COMP-II had cytostatic activity at low concentrations (10~0.3), but other compounds revealed little effect on tumor growth at the low concentration.
|
|
KEYWORD
|
|
Cisplatin, Cytotoxicity, Human cancer cells
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|